Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
7,230
+260
+4% +$38K 0.1% 185
2025
Q4
$847K Buy
6,970
+670
+11% +$78.6K 0.08% 205
2025
Q3
$680K Buy
6,300
+840
+15% +$78.4K 0.07% 228
2025
Q2
$489K Buy
5,460
+330
+6% +$24.8K 0.06% 262
2025
Q1
$349K Sell
5,130
-310
-6% -$22.3K 0.04% 293
2024
Q4
$343K Buy
5,440
+180
+3% +$12.2K 0.04% 302
2024
Q3
$339K Buy
5,260
+610
+13% +$47.9K 0.04% 302
2024
Q2
$383K Buy
4,650
+300
+7% +$22.2K 0.06% 265
2024
Q1
$309K Sell
4,350
-360
-8% -$23.1K 0.05% 300
2023
Q4
$275K Buy
+4,710
New +$245K 0.04% 387

Other funds holding KLAC

Continuum Advisory's KLAC Position: Q1 2026 in Review

Continuum Advisory increased its KLA (KLAC) stake by 3.7% in Q1 2026, buying an estimated $38K and bringing the position to 7,230 shares worth $1.06M. The position accounts for 0.1% of the portfolio, ranked #185.

Continuum Advisory first reported a position in KLAC in Q4 2023 and has held it in 10 quarters since. 2,064 funds tracked by Wall St. Rank hold KLAC as of Q1 2026.

  • Continuum Advisory held 7,230 shares of KLA worth $1.06M as of Q1 2026.
  • Continuum Advisory bought 260 KLA shares in Q1 2026, an estimated $38K.
  • KLA made up 0.1% of Continuum Advisory's portfolio in Q1 2026, its #185 holding.
  • Continuum Advisory first reported a position in KLA in Q4 2023 and has held it in 10 quarters since.
  • 2,064 funds tracked by Wall St. Rank held KLA as of Q1 2026.

Based on Continuum Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.